Department of Neonatology, University Hospital Zurich, Zurich, Switzerland.
Child Development Center, University Children's Hospital Zurich, Zurich, Switzerland.
JAMA. 2020 Dec 8;324(22):2324-2327. doi: 10.1001/jama.2020.19395.
This study reports 5-year neurodevelopmental outcomes for Swiss children born before 32 weeks’ gestation and randomized at birth to receive early high-dose recombinant human erythropoietin (rhEpo) vs placebo.
本研究报告了瑞士胎龄<32 周出生的婴儿在出生时随机接受早期高剂量重组人红细胞生成素(rhEpo)与安慰剂治疗的 5 年神经发育结局。